Chiesi Revcovi injection recalled for failed stability specifications
Chiesi USA, Inc. is recalling Revcovi (elapegademase-lvlr) Injection due to out-of-specification stability results in the protein concentration profile. The affected lot was distributed to Missouri and Tennessee. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Chiesi recalls
What to do
- If you have a vial from lot #1221973 (expiration 3/24/2027), contact your healthcare provider or pharmacist immediately.
- Do not use the recalled medication without consulting your healthcare provider.
- Return the medication to your pharmacy for proper handling.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
- Sold in
- MO, TN
- Made for
- All ages (0 months and older)
Details
- Units affected
- 3,002 vials
- Illnesses reported
- None reported
- Manufactured in
- 175 Regency Woods Pl Ste 600, N/A, Cary, NC, United States
- Classification
- Class III
- Recall number
- D-0838-2026
In the FDA's words
- Description
- Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01 Failed Stability Specifications: Out of specification stability result for the protein concentration profile. Lot#: 1221973, Exp 3/24/2027 Distribution: MO, TN Affected quantity: 3,002 vials
- Hazard
- Failed Stability Specifications: Out of specification stability result for the protein concentration profile.